Search results
Top U.S. drug agency a notable holdout in Biden’s push to loosen federal marijuana restrictions
Sun-Sentinel· 7 days agoIn an isolated part of the U.S. Drug Enforcement Administration headquarters known as the 12th-floor...
U.S. to deploy more than $50M to shield private hospitals from cyberattacks
Crain's New York Business· 7 days agoA Department of Health and Human Services agency will deploy more than $50 million to organizations that create tools to ensure these devices are kept safe and functional. HHS
Doctors: UnitedHealth Group Should Be Responsible For Cyberattack Breach Notices
Forbes· 5 days agoIn a letter this week to the U.S. Department of Health and Human Services Secretary Xavier Becerra...
Second avian flu human case detected in Michigan farmworker
Politico· 5 days ago“According to the Centers for Disease Control, the risk to the public remains low; the Michigan...
Latest 340B ruling delivers blow to providers
Healthcare Dive via Yahoo Finance· 5 days agoDrugmakers are allowed to impose conditions on which pharmacies they dispense discounted drugs to in the 340B program, according to an appellate court.
Top U.S. drug agency a holdout in Biden's push to loosen marijuana restrictions
The Day· 1 day agoDEA Administrator Anne Milgram speaks during a news conference at the Justice Department in...
DOJ Proposes Rule to Reschedule Cannabis From Schedule I to Schedule III | JD Supra
JD Supra· 6 days agoSchedule III drugs are defined as having moderate to low potential for psychical and psychological dependence, and have less abuse potential than Schedule I. Cannabis will remain a Schedule ...
As Scrutiny Escalates, DOJ Announces the Formation of the Health Care Monopolies and Collusion Task...
The National Law Review· 5 days agoThe U.S. Department of Justice (“DOJ”) recently announced the creation of the Health Care Monopolies...
DEA kicks off public comment on cannabis rescheduling
NJBIZ· 5 days agoThe U.S. Drug Enforcement Administration kicked off a public comment period for its formal proposal to reclassify marijuana as a less dangerous substance. Under the framework published May 21 ...
House E&C hones in on accelerated approvals
Axios· 5 days agoThe FDA's drug approvals and oversight of lab-developed tests are again emerging as hot topics as House Republicans crank up oversight of the agency and...
